Global Asthma and COPD Drug Market Research Report 2023(Status and Outlook)


Attention: There is an updated edition available for this report.

Global Asthma and COPD Drug Market Research Report 2023(Status and Outlook)



Report Overview

Asthma and chronic obstructive pulmonary disease (Asthma/COPD) are a common type of chronic disease. Once they are sick, they usually need long-term medication, which seriously affects people's quality of life.

The 2016 Global Asthma Prevention Initiative (GINA) organization has re-released its Consensus on Asthma, COPD and Asthma-COPD Overlap Syndrome, developed in collaboration with the Global Scientific Committee on Chronic Obstructive Pulmonary Disease Prevention (GOLD). A method of identifying such patients is provided.

The Global Asthma and COPD Drug Market Size was estimated at USD 12560 million in 2022 and is projected to reach USD 14727.16 million by 2029, exhibiting a CAGR of 2.30% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Asthma and COPD Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Asthma and COPD Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Asthma and COPD Drug market in any manner.

Global Asthma and COPD Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Boehringer Ingelheim

GlaxoSmithKline

Merck and Co

Novartis AG

AstraZeneca

F. Hoffmann-La Roche

Market Segmentation (by Type)

Bronchodilators

Anti-inflammatory Drugs

Monoclonal Antibodies

Combination Drugs

Market Segmentation (by Application)

Bakery & Confectionery

Meat Alternatives

Functional Foods

Dairy Replacements

Infant Foods

Feed

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Asthma and COPD Drug Market

Overview of the regional outlook of the Asthma and COPD Drug Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Asthma and COPD Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Asthma and COPD Drug
1.2 Key Market Segments
1.2.1 Asthma and COPD Drug Segment by Type
1.2.2 Asthma and COPD Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Asthma and COPD Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Asthma and COPD Drug Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Asthma and COPD Drug Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Asthma and COPD Drug Market Competitive Landscape
3.1 Global Asthma and COPD Drug Sales by Manufacturers (2018-2023)
3.2 Global Asthma and COPD Drug Revenue Market Share by Manufacturers (2018-2023)
3.3 Asthma and COPD Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Asthma and COPD Drug Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Asthma and COPD Drug Sales Sites, Area Served, Product Type
3.6 Asthma and COPD Drug Market Competitive Situation and Trends
3.6.1 Asthma and COPD Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Asthma and COPD Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Asthma and COPD Drug Industry Chain Analysis
4.1 Asthma and COPD Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Asthma and COPD Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Asthma and COPD Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Asthma and COPD Drug Sales Market Share by Type (2018-2023)
6.3 Global Asthma and COPD Drug Market Size Market Share by Type (2018-2023)
6.4 Global Asthma and COPD Drug Price by Type (2018-2023)
7 Asthma and COPD Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Asthma and COPD Drug Market Sales by Application (2018-2023)
7.3 Global Asthma and COPD Drug Market Size (M USD) by Application (2018-2023)
7.4 Global Asthma and COPD Drug Sales Growth Rate by Application (2018-2023)
8 Asthma and COPD Drug Market Segmentation by Region
8.1 Global Asthma and COPD Drug Sales by Region
8.1.1 Global Asthma and COPD Drug Sales by Region
8.1.2 Global Asthma and COPD Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Asthma and COPD Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Asthma and COPD Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Asthma and COPD Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Asthma and COPD Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Asthma and COPD Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Asthma and COPD Drug Basic Information
9.1.2 Boehringer Ingelheim Asthma and COPD Drug Product Overview
9.1.3 Boehringer Ingelheim Asthma and COPD Drug Product Market Performance
9.1.4 Boehringer Ingelheim Business Overview
9.1.5 Boehringer Ingelheim Asthma and COPD Drug SWOT Analysis
9.1.6 Boehringer Ingelheim Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Asthma and COPD Drug Basic Information
9.2.2 GlaxoSmithKline Asthma and COPD Drug Product Overview
9.2.3 GlaxoSmithKline Asthma and COPD Drug Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Asthma and COPD Drug SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 Merck and Co
9.3.1 Merck and Co Asthma and COPD Drug Basic Information
9.3.2 Merck and Co Asthma and COPD Drug Product Overview
9.3.3 Merck and Co Asthma and COPD Drug Product Market Performance
9.3.4 Merck and Co Business Overview
9.3.5 Merck and Co Asthma and COPD Drug SWOT Analysis
9.3.6 Merck and Co Recent Developments
9.4 Novartis AG
9.4.1 Novartis AG Asthma and COPD Drug Basic Information
9.4.2 Novartis AG Asthma and COPD Drug Product Overview
9.4.3 Novartis AG Asthma and COPD Drug Product Market Performance
9.4.4 Novartis AG Business Overview
9.4.5 Novartis AG Asthma and COPD Drug SWOT Analysis
9.4.6 Novartis AG Recent Developments
9.5 AstraZeneca
9.5.1 AstraZeneca Asthma and COPD Drug Basic Information
9.5.2 AstraZeneca Asthma and COPD Drug Product Overview
9.5.3 AstraZeneca Asthma and COPD Drug Product Market Performance
9.5.4 AstraZeneca Business Overview
9.5.5 AstraZeneca Asthma and COPD Drug SWOT Analysis
9.5.6 AstraZeneca Recent Developments
9.6 F. Hoffmann-La Roche
9.6.1 F. Hoffmann-La Roche Asthma and COPD Drug Basic Information
9.6.2 F. Hoffmann-La Roche Asthma and COPD Drug Product Overview
9.6.3 F. Hoffmann-La Roche Asthma and COPD Drug Product Market Performance
9.6.4 F. Hoffmann-La Roche Business Overview
9.6.5 F. Hoffmann-La Roche Recent Developments
10 Asthma and COPD Drug Market Forecast by Region
10.1 Global Asthma and COPD Drug Market Size Forecast
10.2 Global Asthma and COPD Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Asthma and COPD Drug Market Size Forecast by Country
10.2.3 Asia Pacific Asthma and COPD Drug Market Size Forecast by Region
10.2.4 South America Asthma and COPD Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Asthma and COPD Drug by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Asthma and COPD Drug Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Asthma and COPD Drug by Type (2024-2029)
11.1.2 Global Asthma and COPD Drug Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Asthma and COPD Drug by Type (2024-2029)
11.2 Global Asthma and COPD Drug Market Forecast by Application (2024-2029)
11.2.1 Global Asthma and COPD Drug Sales (K MT) Forecast by Application
11.2.2 Global Asthma and COPD Drug Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings